The company introduced a new system to strengthen internal training
Release time:
2020-07-22
Team Building Set Specification Strong Management Seeking Actual Effect
Company Introduced New System to Strengthen Internal Training
This newspaper After discussion and approval at the group office meeting, the company's "Internal Trainer Team Building and Management Measures" was recently released and implemented.
The formulation of this management method is to speed up the construction of the talent team, realize the accumulation and inheritance of corporate capabilities and experience, and establish and train an excellent internal training team for the company's employees' shortcomings in work capabilities and training needs. Teacher team. The establishment of the internal trainer team not only realizes the standardization of the management of the internal trainer team, meets the needs of the company's staff training at all levels, and ensures the smooth implementation of the company's strategic development, but also helps to enhance the pertinence and effectiveness of staff training. Really help employees improve work efficiency and improve work performance.
According to the relevant provisions of the management measures, internal trainers will be selected from employees with formal labor relations (or labor dispatch personnel) within the group company, with intermediate or above professional titles, secondary (technician) or above professional qualifications, and tertiary or above qualifications (one of the three). The selection criteria are: identify with peak culture and values, be enthusiastic about the trainer's profession and be willing to assume corresponding responsibilities; Have profound knowledge and skills accumulation in a certain professional field, and have good work performance and behavior attitude performance; Have the potential of internal trainers: have good speech expression ability; Have experience or ability to develop courses.
According to the different training contents, internal trainers are divided into two categories: general category and professional category (skill category). Among them, general category mainly includes courses in operation and management, such as safety and environmental protection management, financial management, administrative management, sales management, human resources management, bidding management, investment decision-making, legal risk management, etc. Professional category (skill category) mainly includes technical courses related to various industries, such as cement technology, equipment maintenance, electrical management, drug research and development, product quality management, procurement and storage management, trade circulation, etc.
Employees who meet the internal trainer selection criteria shall be determined by group companies, professional companies and directly affiliated enterprises according to the needs and actual needs of each unit after being recommended by individuals and recommended by units, and passing the corresponding qualification examination. General trainers shall be determined by CNPC, and professional trainers (skills) shall be determined by each professional company and directly affiliated enterprise, and shall be reported to CNPC for record. The final selected internal trainers shall be uniformly announced by the group company below, and shall be appointed by each unit for two years.
For those selected into the internal trainer team, the company will train and improve their expression ability and methods, training in curriculum and teaching materials compilation methods, teaching arrangement and implementation methods, understanding of external information, and updating of experience reserves. During the employment period, the internal trainer needs to take on the responsibility of compiling and developing the corresponding course teaching materials, teaching not less than six hours or two training hours per year, and decide whether to continue the employment after being "qualified" in the satisfaction survey of the trainees and passing the examination of the unit to which he belongs. (this newspaper reporter)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page